Augury

1.1 Identity, product, and footprint

Augury positions itself as industrial AI for uptime and productivity: machine-health monitoring, process-health optimization, and role-based AI agents for manufacturing plants. The company says its systems combine sensors, analytics, and expert services to reduce downtime, improve yield, and support sustainability. Public profiles converge on 2011 as the founding year, New York as the headquarters, and Israel-based R&D and offices as part of the operating footprint. The refresh also shows that the company is broadening from an equipment sensor story into a larger plant-context and workflow story, which matters for future budget expansion, cross-sell, account expansion, partner depth, scale, overall now.[CO001, CO002, CO004, CO008]

1.2 Leadership, governance, and capital

The current executive stack is broader than the original founder pair and now includes Elan Greenberg as CEO, Saar Yoskovitz as executive chairman, Brian Germain as CRO, Ori Franco as CFO, and Anoop Mohan as CPTO. Funding remains a key part of the story: Augury closed a $75 million Series F in February 2025, kept its $1 billion valuation, and reported a total raised figure near $369 million across eight rounds. Strategic investors such as Lightrock, Baker Hughes, Insight Partners, Eclipse, Qumra Capital, Qualcomm Ventures, SE Ventures, and Munich Re recur across the financing trail. That mix matters because it anchors both industrial credibility and late-stage financing support.[CO003, CO005, CO006, CO007]

1.3 Milestones and refresh gaps

Since the prior refresh, the company has pushed beyond machine health into process health, launched an open industrial profile for Google Cloud's Open Knowledge Format, and continued to frame its value proposition around trusted AI for brownfield manufacturing environments. The main refresh gap is scale precision: third-party sources disagree on current headcount, and revenue remains a mix of company quotes and third-party estimates rather than audited disclosure. That makes the company feel more mature operationally than financially transparent, even though the 2026 narrative is clearly more expansive than the old sensor-only framing.[CO009, CO010, CO011, CO012]

1.4 Exhibits

2.1 Market boundary and buyer

The relevant market is not generic AI; it is the manufacturing reliability stack where plants buy monitoring, diagnostics, and optimization to reduce downtime and improve throughput. Buyers are usually reliability, maintenance, operations, or plant leaders, sometimes with procurement and IT / OT gating the decision. That means the market is shaped as much by integration and trust as by raw software feature breadth, and by the ability to justify attention on the plant floor. In other words, budget ownership is technical, operational, and political at the same time. The buying committee usually wants proof that the system works on existing equipment, not just in greenfield demos. That pushes vendors to sell implementation confidence, not just software features.[CM001, CM002, CM003, CM004]

2.2 Sizing lenses and adoption

Public sizing is best understood as a set of imperfect lenses: an older McKinsey estimate for predictive factory maintenance, ABI Research category coverage for industrial and manufacturing markets, and Gartner's 2026 market guide for APM software. None of these gives a single clean answer, but together they confirm that Augury sits inside a sizable, analyst-recognized industrial software segment with real budget ownership. The practical takeaway is that the category is big enough to matter, even if no single source nails the exact overlap. That makes the sizing exercise directional rather than precise, and the market boundary should be read as a working thesis rather than a fact table.[CM005, CM006, CM007, CM008]

2.3 Growth drivers and constraints

The growth case is straightforward: aging workforce, downtime pressure, sustainability goals, and the need to extract more output from existing assets. The constraint set is equally clear: brownfield integration, long sales cycles, trust in recommendations, and the possibility that incumbents or OEMs bundle enough functionality to blunt a pure-play pitch. The market should therefore grow, but not frictionlessly, and buyer confidence will remain a gating variable. If the vendor cannot reduce plant complexity, the category will still grow but adoption will lag the hype cycle. That creates a steady market, not a shortcut to rapid standardization, and it keeps services central to the sell.[CM009, CM010, CM011, CM012]

2.4 Exhibits

3.1 Direct competitors and specialists

The strongest direct competitors are other predictive-maintenance and asset-analytics vendors. Public competitor lists repeatedly surface Uptake, TRACTIAN, Infinite Uptime, I-Care, Uptime AI, Nanoprecise, Falkonry, CorrosionRADAR, Novity, SparkCognition, and MachineMetrics. These vendors vary by geography and product emphasis, but they all attack the same buyer budget: reduce unplanned downtime and improve equipment reliability. The crowded field matters because the buyer usually has several ways to solve the same reliability pain, and any one plant may evaluate several vendors before standardizing. That makes brand, services, and implementation quality especially important, and it keeps price pressure alive.[CP001, CP002, CP003, CP004]

3.2 Adjacent substitutes and incumbents

Not every alternative is a pure Augury clone. Incumbent industrial software suites, equipment OEMs, and edge / fleet-management platforms can absorb some of the same budget if they bundle analytics with existing plant systems. The market is therefore not only a startup race; it is also a packaging and distribution race against larger industrial software stacks. That makes the substitute set strategically important even when it does not look like a direct product comparison, because the buyer can solve the problem indirectly. In some deals, the substitute is really the customer's existing operating stack, which makes replacement inertia a real barrier.[CP005, CP006, CP007, CP008]

3.3 Differentiation and durability

Augury's best differentiation story is the combination of machine-health data scale, prescriptive diagnostics, process-health expansion, and service-heavy deployment help. That is credible, but the moat is not absolute: public comparison pages still note limited OT protocol coverage, deployment effort, and pricing opacity. The company's edge therefore looks real but workmanlike rather than unassailable, and it will depend on how much plant workflow it can own. That is the core diligence question in a category where feature parity can arrive quickly. The more workflow the platform controls, the harder it is to swap, but the more support it must deliver. Execution quality is therefore part of the moat, and so is customer success.[CP009, CP010, CP011, CP012]

3.4 Exhibits

4.1 Funding history and ownership

Augury's financing trail runs from a 2014 seed round to a February 2025 Series F. Public sources agree on the $75 million Series F and the $1 billion valuation, but the exact total raised varies slightly by source. The company's investor base mixes industrial strategics, software VCs, and climate / infrastructure investors, which suggests the capital stack is as strategic as it is financial. That matters because industrial AI buyers often read investor quality as a proxy for persistence, support depth, and follow-on capital access. The funding path also signals that the company has been able to keep interest from both strategic and financial backers for a long time.[CI001, CI002, CI003, CI004]

4.2 Revenue, ARR, and growth signals

The company and its third-party profiles cite strong top-line momentum: revenue reportedly increased five-fold since the 2021 round, a 2026 profile lists $155 million ARR, and the CEO said Augury expected to reach $100 million ARR in the coming year. These are not audited figures, but they are consistent with the company's late-stage growth narrative and unicorn valuation. The practical underwriting question is whether the growth is broad-based plant adoption or a narrower set of large accounts compounding over time. If the latter is true, the number can still be large while the underlying revenue quality remains less diversified than it first appears.[CI005, CI006, CI007, CI008]

4.3 Disclosure quality and capital efficiency

The main financial diligence issue is disclosure quality rather than direction of travel. Different public databases disagree on total raised by a few million dollars, and profit, margin, retention, and burn are not publicly audited. That leaves the company investable as a scaled industrial software story, but it still needs private-market style skepticism on unit economics and capital efficiency. Until the company publishes a tighter financial bridge, the best view is that revenue quality is plausible but only partially verifiable. That is a solvable problem, but it remains a real underwriting gap.[CI009, CI010, CI011, CI012]

4.4 Exhibits

5.1 Core platform architecture

The core stack starts with sensors and machine telemetry, then pushes data into analytics systems that help diagnose failure modes, prioritize alerts, and recommend corrective action. Public material repeatedly references vibration, sound, temperature, magnetic fields, and machine readings as the input layer. The latest company messaging also stresses that Augury now packages machine health and process health into AI agents that can act across the plant workflow rather than just alert on anomalies. That makes the platform feel more like a decision layer than a single-purpose monitoring tool, and it helps explain why the company talks about workflow and knowledge capture. The architecture is therefore broader than a sensor bundle and narrower than a general industrial ERP layer.[CE001, CE002, CE003, CE004]

5.2 Deployment model and cloud integration

The company's reference implementations show a hybrid deployment model: Google Cloud for data processing and AI training, Azure / AKS for some customer workloads, and production integrations that must work across brownfield manufacturing environments. That is a real advantage for reach, but it also means Augury has to earn trust on uptime, cost, and integration complexity at every customer site. In practice, the deployment model is as much about field reliability as it is about cloud architecture, because a weak rollout can erase the benefit of a strong model. The more plants it covers, the more operational discipline matters.[CE005, CE006, CE007, CE008]

5.3 Open standards and product expansion

In 2026 Augury moved beyond pure monitoring into an open-source industrial profile for Google Cloud's Open Knowledge Format. That matters because it turns the company from a device-and-model vendor into a potential context layer for manufacturing AI. The product surface is therefore broader than machine health: it now includes process optimization, role-based agents, and a vocabulary for human-verified plant knowledge. That expansion is strategically useful, but it also widens the implementation surface and the diligence burden. The upside is platform leverage; the downside is more places for execution to slip. This is the classic tradeoff when a point solution becomes a platform.[CE009, CE010, CE011, CE012]

5.4 Exhibits

6.1 Named customers and breadth

Across company press, customer case studies, and buyer-intent databases, Augury is repeatedly associated with large manufacturers in food, beverage, CPG, chemicals, and industrial equipment. The consistent pattern is not a single marquee logo but a portfolio of deployments across many plants, with the company stressing global reach and broad customer trust. That suggests the buyer motion is enterprise-led and account expansion matters as much as logo count. It also implies that the sales motion is likely multi-site and relationship-driven rather than purely transactional. In that setup, plant-level wins can expand into broader account coverage and become sticky operational programs. The customer base therefore looks broad, but not necessarily shallow.[CU001, CU002, CU003, CU004]

6.2 Operational outcomes and ROI claims

The strongest customer evidence comes from case studies and press claims: less downtime, fewer failures, better yield, lower energy use, and quicker maintenance response. The numbers are mostly company-quoted or partner-quoted, but they do point to a product that is judged on financial impact rather than only on technical accuracy. In diligence terms, that means the commercial question is whether those outcomes recur consistently enough to drive renewals and expansion. If the ROI is real but too site-specific, the story remains useful but not yet fully scalable. The key question is whether the gains survive broader deployment and whether plant teams actually keep using the system. That is ultimately a retention question, not just a launch question.[CU005, CU006, CU007, CU008]

6.3 Coverage gaps and concentration risk

The customer story is still partly anecdotal. Public sources do not fully disclose retention, concentration, or logo-by-logo churn, so the refresh can confirm usage breadth but not contract durability. That leaves room for upside if the install base keeps expanding, but it also keeps customer concentration and renewal quality as open diligence items. The most useful next proof would be named renewals, cohort retention, or expansion-by-site evidence, ideally from sources that are not company-authored. The public record is strong on logos and weaker on durability, which keeps underwriting cautious and makes renewal evidence disproportionately valuable.[CU009, CU010, CU011, CU012]

6.4 Exhibits

7.1 Deployment, implementation, and product risk

Augury sells into brownfield manufacturing environments where integrations are messy, uptime expectations are high, and change management is hard. That means the product has to work in the plant, not just in a demo. The same complexity that makes the platform valuable also makes pilots, rollouts, and support expensive. The operational risk is therefore less about one catastrophic bug and more about repeated friction across many plants. Every extra integration step can slow adoption and increase service burden. If support quality slips, the margin impact can compound quickly. This is the kind of risk that shows up as slower expansion rather than a visible outage, which makes it easier to miss early.[CR001, CR002, CR003, CR004]

7.2 Commercial and financial risk

The commercial story is strong but still imperfectly disclosed. Public sources point to growth, yet they also show a company that is still privately held, still using estimates for revenue and headcount, and still relying on a concentrated set of large manufacturers to validate the model. The risk is less that the company does not work and more that the economics are harder to scale than the branding suggests. Disclosure gaps keep this from underwriting like a mature public software name, and they leave too much room for margin surprises. That is especially true if customer concentration turns out to be higher than the logos imply, or if renewals require more service than the company admits. The market can still reward the story while penalizing the opacity.[CR005, CR006, CR007, CR008]

7.3 External and market risk

Manufacturing buyers are under pressure from staffing shortages, volatile supply chains, and capex scrutiny, but those same conditions make budget cycles long and buying committees cautious. Augury also has to defend against incumbent industrial software stacks and point solutions that can be cheaper or easier to standardize at scale. That means category growth is real, but so is substitution risk. If the buyer can get 70% of the value from an incumbent suite, pricing power gets harder. Competitive pressure therefore shows up both in win rates and in renewal negotiations, especially when buyers compare total cost of ownership rather than point accuracy. The result is a market where differentiation must stay visible year after year.[CR009, CR010, CR011, CR012]

7.4 Exhibits

8.1 Current valuation frame

Public sources continue to anchor Augury at about $1 billion after the February 2025 round. The company also keeps pointing to strong customer ROI and expanding product scope, which helps explain why it can still be financed as a unicorn even without public-market scale. The question is less whether the business has value and more what multiple is justified for a still-private industrial AI vendor. Put differently, the market is paying for proof of durable plant-level adoption, not just for a good story, and the public evidence is only partially complete. That leaves the company in a familiar late-stage private-market zone where it is real, valuable, and still hard to price exactly.[CV001, CV002, CV003, CV004]

8.2 Public multiples and private comps

The company profile implies a revenue multiple in the high single digits to low double digits depending on whether you use the $100 million, $155 million, or company-quoted revenue basis. That makes the valuation look plausible for a fast-growing industrial software vendor, but not obviously cheap. The refresh does not provide enough audited data to argue for a cheaper stance than fair, and the peer set remains too noisy to anchor a precise discount or premium. In other words, the range is useful for framing but not for precision. The right mental model is a valuation band, not a point estimate.[CV005, CV006, CV007, CV008]

8.3 Stance and scenarios

The base case is that Augury deserves a premium software multiple if growth stays strong and the process-health expansion holds. The bear case is that disclosure opacity, support burden, and customer concentration erode confidence in the revenue quality behind the multiple. That is why the valuation stance remains fair rather than attractive, with upside only if the company can convert product breadth into cleaner, repeatable economics. The public record still reads like a solid business priced at a solid multiple, and the decision mainly turns on conviction in durability.[CV009, CV010, CV011, CV012]

8.4 Exhibits